Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 29, 2017	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001193125-17-218303.pdf 0001193125-17-218303.rtf 0001193125-17-218303.xls View HTML
June 29, 2017	8-K	Report of unscheduled material events or corporate event	0001193125-17-218379.pdf 0001193125-17-218379.rtf 0001193125-17-218379.xls View HTML
July 6, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002433.pdf 0001562180-17-002433.rtf 0001562180-17-002433.xls View HTML
July 6, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002434.pdf 0001562180-17-002434.rtf 0001562180-17-002434.xls View HTML
July 6, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002435.pdf 0001562180-17-002435.rtf 0001562180-17-002435.xls View HTML
July 11, 2017	4	Statement of changes in beneficial ownership of securities	0000899243-17-018170.pdf 0000899243-17-018170.rtf 0000899243-17-018170.xls View HTML
July 14, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-228620.pdf 0001193125-17-228620.rtf 0001193125-17-228620.xls View HTML
August 8, 2017	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-17-016542.pdf 0001564590-17-016542.rtf 0001564590-17-016542.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
August 10, 2017	SC 13D/A	An amendment to a SC 13D filing	0001193125-17-254489.pdf 0001193125-17-254489.rtf 0001193125-17-254489.xls View HTML
August 17, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-002729.pdf 0001562180-17-002729.rtf 0001562180-17-002729.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax